<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00521443</url>
  </required_header>
  <id_info>
    <org_study_id>AH-05/04</org_study_id>
    <nct_id>NCT00521443</nct_id>
  </id_info>
  <brief_title>Cryosurvival of Embryos From Dysmorphic Oocytes</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>V.K.V. American Hospital, Istanbul</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>V.K.V. American Hospital, Istanbul</source>
  <brief_summary>
    <textblock>
      Various morphological abnormalities of human oocytes were reported to detrimentally affect
      embryo development. We observed development of frozen thawed embryos derived from oocytes
      with normal or abnormal morphological features to the blastocyst stage. Cytoplasmic
      abnormalities of the oocytes were found to negatively affect cryosurvival potential of the
      embryos.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>12</number_of_groups>
  <condition>Cryopreservation</condition>
  <condition>Blastocyst</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_type>Control</arm_group_type>
    <description>Embryos derived from morphologically normal MII oocytes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Irregular Shapes</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from irregularly shaped oocytes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Large PVS</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with large perivitelline space.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dark Zona</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with dark zona pellucida</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dark cytoplasm</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with dark cytoplasm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vacuolar cytoplasm</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with vacuolated cytoplasm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Central granulation</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with centrally granulated cytoplasm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double extra</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with double extracytoplasmic abnormalities</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double combined</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with any combination of one extracytoplasmic and one cytoplasmic anomaly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double cytoplasmic</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with any two cytoplasmic anomalies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Triple extra</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with triple extracytoplasmic anomaly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Triple combined</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>Embryos derived from oocytes with triple combined anomalies</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cryopreservation, thawing and blastocyst culture</intervention_name>
    <description>Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.</description>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_label>Irregular Shapes</arm_group_label>
    <arm_group_label>Large PVS</arm_group_label>
    <arm_group_label>Dark Zona</arm_group_label>
    <arm_group_label>Dark cytoplasm</arm_group_label>
    <arm_group_label>Vacuolar cytoplasm</arm_group_label>
    <arm_group_label>Central granulation</arm_group_label>
    <arm_group_label>Double extra</arm_group_label>
    <arm_group_label>Double combined</arm_group_label>
    <arm_group_label>Double cytoplasmic</arm_group_label>
    <arm_group_label>Triple extra</arm_group_label>
    <arm_group_label>Triple combined</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Human embryos derived from morphologically normal or abnormal mature oocytes that
             fertilized normally by microinjection procedure.

          -  Embryos were obtained from couples who refused to freeze their supernumerary embryos
             after fresh embryo transfer in an assisted reproduction treatment cycle.

        Exclusion Criteria:

          -  Embryos obtained after microinjection to immature oocytes taht were in vitro matured
             in culture.

          -  Embryos obtained from abnormally fertilized zygotes.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Basak Balaban, B.Sc.</last_name>
    <role>Study Director</role>
    <affiliation>Assisted Reproduction Unit of the VKV American Hospital of Istanbul</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VKV American Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34365</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2007</study_first_submitted>
  <study_first_submitted_qc>August 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2007</study_first_posted>
  <last_update_submitted>August 24, 2007</last_update_submitted>
  <last_update_submitted_qc>August 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2007</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

